PLUS1
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
|
Pre-Market Last Trade |
Last $ 2.01 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ocugen Inc | OCGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 2.01 | 0.00 | 0.00 | 0.00 | 2.01 | 09:07:06 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.00 | 2.01 | 0.01 | 0.5% | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 65 | 8,071 | 2,084,565 | 1.22 - 3.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:12:52 | 1 | $ 2.01 | USD |
Ocugen Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.17M | 1.58M | -60.00 | - | 1.13M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 0.50% |
Ocugen News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/09/2019 | 07:30 | GlobeNewswire Inc. | Ocugen Announces Share Repurchase Program |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.43 | 2.73 | 1.3 | 1.9937 | 4M | 0.58 | 40.56% |
| 1 Month | 3.24 | 3.35 | 1.22 | 1.8114 | 4M | -1.23 | -37.96% |
| 3 Months | 3.24 | 3.35 | 1.22 | 1.8114 | 4M | -1.23 | -37.96% |
| 6 Months | 3.24 | 3.35 | 1.22 | 1.8114 | 4M | -1.23 | -37.96% |
| 1 Year | 3.24 | 3.35 | 1.22 | 1.8114 | 4M | -1.23 | -37.96% |
| 3 Years | 3.24 | 3.35 | 1.22 | 1.8114 | 4M | -1.23 | -37.96% |
| 5 Years | 3.24 | 3.35 | 1.22 | 1.8114 | 4M | -1.23 | -37.96% |
Ocugen Description
| Ocugen Inc is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. |
